Amundi
RMD icon

Amundi’s ResMed RMD Stock Holding History

Amundi’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
604,304
-457,880
-43% -$94.9M 0.03% 422
2026
Q1 		$238M Buy
1,062,184
+587,872
+124% +$146M 0.07% 256
2025
Q4 		$114M Buy
474,312
+83,171
+21% +$21.3M 0.03% 443
2025
Q3 		$110M Sell
391,141
-28,790
-7% -$7.86M 0.04% 379
2025
Q2 		$107M Sell
419,931
-211,218
-33% -$50.4M 0.04% 398
2025
Q1 		$135M Buy
631,149
+40,937
+7% +$9.56M 0.05% 336
2024
Q4 		$139M Buy
590,212
+23,775
+4% +$5.72M 0.05% 347
2024
Q3 		$134M Buy
566,437
+125,844
+29% +$28.1M 0.05% 334
2024
Q2 		$83.4M Buy
440,593
+23,656
+6% +$4.8M 0.03% 416
2024
Q1 		$74.1M Sell
416,937
-198,061
-32% -$36.3M 0.03% 437
2023
Q4 		$109M Sell
614,998
-379,967
-38% -$58.4M 0.05% 367
2023
Q3 		$140M Buy
994,965
+311,563
+46% +$56.3M 0.07% 295
2023
Q2 		$147M Sell
683,402
-321,962
-32% -$71.8M 0.07% 286
2023
Q1 		$222M Buy
1,005,364
+227,769
+29% +$49.4M 0.12% 190
2022
Q4 		$167M Sell
777,595
-83,808
-10% -$18.4M 0.09% 241
2022
Q3 		$200M Buy
861,403
+12,142
+1% +$2.76M 0.12% 194
2022
Q2 		$188M Sell
849,261
-447
-0.1% -$95.2K 0.15% 159
2022
Q1 		$214M Buy
849,708
+161,046
+23% +$39M 0.15% 162
2021
Q4 		$173M Sell
688,662
-47,936
-7% -$12.4M 0.11% 207
2021
Q3 		$194M Sell
736,598
-27,274
-4% -$7.46M 0.14% 179
2021
Q2 		$188M Buy
+763,872
New +$161M 0.13% 181

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Amundi's RMD Position: Q2 2026 in Review

Amundi reduced its ResMed (RMD) stake by 43% in Q2 2026, selling an estimated $94.9M and leaving 604,304 shares worth $118M. The position accounts for 0.03% of the portfolio, ranked #422.

Amundi first reported a position in RMD in Q2 2021 and has held it in 21 quarters since. The position peaked at $238M in Q1 2026. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Amundi held 604,304 shares of ResMed worth $118M as of Q2 2026.
  • Amundi sold 457,880 ResMed shares in Q2 2026, an estimated $94.9M.
  • ResMed made up 0.03% of Amundi's portfolio in Q2 2026, its #422 holding.
  • Amundi first reported a position in ResMed in Q2 2021 and has held it in 21 quarters since.
  • Amundi's ResMed position peaked at $238M in Q1 2026.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.